Mallinckrodt Provides Regulatory Update on StrataGraft®
- Friday, February 12, 2021, 7:14
- PR Newswire
- Add a comment
DUBLIN, Feb. 12, 2021 /PRNewswire/ — Mallinckrodt plc, a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that it is deferring action (pending a site inspection) on the Stratatech Biologics License Application…
About the Author
admin has written 21653 stories on this site.